MKI67 and lung cancer: These findings, along with the significant reduction in Ki-67 LI in the proximal bronchi, and favorable modulations of a variety of other eicosanoids, as well as a reduction in lung cancer cell proliferation by post-LP-treatment BAL fluids from our previous reports [10], further support the potential of oral LP in dampening the driving forces of cancerization in the lungs.